Shannon Verma, MD
Dermatology · Dayton, OHNPI 1689771933
Payments from drug & device makers
Across 868 payments — averaging $16.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$3K
- AbbVie$2K
- Sanofi$961
- Regeneron Healthcare Solutions, Inc.$771
- Lilly USA, LLC$735
- LEO Pharma Inc.$663
- plus $6K from 31 others
What the payments were for
- Food & beverage$14,02197%
- Education$4323%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 187 | $3,410 |
| AbbVie | 176 | $2,237 |
| Sanofi | 48 | $961 |
| Regeneron Healthcare Solutions, Inc. | 38 | $771 |
| Lilly USA, LLC | 37 | $735 |
| LEO Pharma Inc. | 38 | $663 |
| Pfizer | 40 | $626 |
| UCB, Inc. | 25 | $594 |
| Incyte Corporation | 44 | $571 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 63 | $570 |
| E.r. Squibb & Sons, L.L.C. | 26 | $524 |
| Novartis | 19 | $328 |
| Galderma Laboratories, L.p. | 16 | $299 |
| Dermavant Sciences, Inc. | 18 | $281 |
| Boehringer Ingelheim | 10 | $222 |
| Sun Pharmaceutical Industries Inc. | 14 | $219 |
| VYNE Pharmaceuticals Inc. | 9 | $155 |
| Mayne Pharma Commercial LLC | 9 | $154 |
| Journey Medical Corporation | 8 | $150 |
| Regeneron | 1 | $131 |
| Almirall LLC | 7 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Amgen | 6 | $116 |
| Sanofi-aventis U.S. LLC | 2 | $87 |
| Organon | 10 | $66 |
| Dermira, Inc. | 3 | $60 |
| Strata Skin Sciences, Inc. | 1 | $58 |
| EPI Health, LLC | 2 | $43 |
| Springworks Therapeutics, Inc. | 1 | $29 |
| Bristol Myers Squibb | 2 | $24 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $17 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $16 |
| Ironwood Pharmaceuticals, Inc | 1 | $16 |
| Genentech USA, Inc. | 1 | $16 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,453 in reported general payments places this provider in the 80th percentile of 460 dermatology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 27 | $98,105 |
| Enbrel SureclickEtanercept | 13 | $95,312 |
| Humira(Cf) PenAdalimumab | 13 | $82,470 |
| Dupixent SyringeDupilumab | 14 | $61,809 |
| SiliqBrodalumab | 11 | $59,317 |
| Clindamycin Phosphate | 119 | $5,526 |
| Clobetasol Propionate | 144 | $5,348 |
| Metronidazole | 88 | $4,648 |
| Betamethasone Dipropionate | 138 | $3,994 |
| Tacrolimus | 18 | $3,706 |
| Triamcinolone Acetonide | 346 | $2,968 |
| Doxycycline Hyclate | 145 | $2,818 |
| Fluorouracil | 29 | $1,960 |
| Spironolactone | 125 | $1,539 |
| Ketoconazole | 83 | $1,086 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCSiliq | $570 | $59,31711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 460 dermatology providers in Ohio.
Other dermatology in Dayton
- Jeffrey TraversDayton$4.7M
- Rocco SerraoDayton$3M
- Matthew BakosDayton$169K
- Matthew ZirwasBexley$7.4M
- Neil KormanCleveland$6M
- Jennifer NashWesterville$4M
- Jessica KaffenbergerColumbus$3.2M
- Patrick ShannonBoardman$2M
- George DrewMarion$2M
- Benjamin BoguckiColumbus$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.